Combined Analysis of Phase III Trials Evaluating [99mTc]Tilmanocept and Vital Blue Dye for Identification of Sentinel Lymph Nodes in Clinically Node-Negative Cutaneous Melanoma

Overview of attention for article published in Annals of Surgical Oncology, October 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

blogs: 1 blog
twitter: 2 X users

patent: 2 patents

Citations

dimensions_citation: 135 Dimensions

Readers on

mendeley: 61 Mendeley

Summary Blogs X Patents Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,268 followers.

Nuevo agente que permite detectar mejor l #cancer identificando nódulos linfáticos tumorales #oncologia #cancerdemama http://t.co/QmphzQEW8M

Reply Repost Favourite

CD206 receptor-targeted radiopharmaceutical for #SLN mapping 4 #melanoma http://t.co/iT8onGY7

Reply Repost Favourite